KFDA seeks to overhaul bioequivalence system

Published: 2006-11-23 06:59:00

Updated: 2006-11-23 06:59:00

The Korea Food and Drug Administration (KFDA) said recently that the government plans to ameliorate the current bioequivalence system through the enactment of bioequivalence testing requirements, including designation of eligible testing agency.

The announcement comes at a time when the govern...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK